Home › DDEVPLSTIK › Filing
🔔 Get instant alerts when DDEVPLSTIK files quarterly results on BSE Start free trial →

Investor Presentation

Filed: 13 Nov 2026, 10:27 IST Exchange: NSE Category: Financial Results — Investor Presentation
Investor Presentation - Q2FY27 & H1FY27 - H1FY27 revenue grew 36% YoY to ₹1,968 Cr; EBITDA up 22% YoY at ₹187 Cr with 10% margin; PAT rose 17% YoY to ₹116 Cr - Commissioned 48,000 MTPA XLPE capacity in April 2026; capex of ₹79.22 Cr for capacity additions - Exports contributed 29% to revenue, with focus on international expansion - FY27 growth driven by wires and cables sector, infrastructure, renewables, and operational efficiency - Plans to increase HFFR capacity to 20,000 MTPA and expand XLPE capacity by 6,000 MTPA by FY27 - Strong balance sheet with net debt-free status maintained since 4QFY24 - Management targets INR 5,000 Cr capex by FY30 to support growth and capacity expansion
Source: Original filing PDF — view on exchange portal
⚡ You're reading this after the fact — subscribers got it instantly
ISA
Indian Stock Alerts BOT
🚨 DDEVPLSTIK — Quarterly Results
Revenue: ₹2,35,800 Cr (+12% YoY)
PAT: ₹19,200 Cr (+17% YoY)
EBITDA margin: 16.8%
Board declared ₹10/share dividend. Jio adds 8M subs.
✓✓ 6:47 PM
🎧
Instant audio summaries2-min AI concall recap delivered with every earnings alert
📊
20-quarter financialsRevenue, PAT, EBITDA, margins — auto-extracted from filings
🔍
Forensic red-flag screenAudit, governance, accruals & RPT flags scored automatically
⚡
Instant Telegram alertsResults, board meetings, insider trades — within minutes

Add DDEVPLSTIK to your watchlist — all of this, automated.

Sign in with Google
14-day Pro trial · No credit card · Cancel anytime

More on Ddev Plastiks Industries Limited

Important. The summary above is generated automatically from Ddev Plastiks Industries Limited's own public regulatory filing under SEBI LODR. Indian Stock Alerts is not a SEBI-registered Research Analyst or Investment Adviser. This page is informational, not investment advice, a recommendation to buy or sell any security, or any opinion about the company's business, governance or financial health. Always read the original filing before acting and consult a registered adviser for investment decisions.